- Book
- April 2018
- 264 Pages
- Book
- February 2018
- 880 Pages
- Book
- August 2017
- 424 Pages
United States
- Book
- March 2016
- 544 Pages
- Book
- December 2011
- 400 Pages
- Book
- February 2009
- 848 Pages
- Book
- February 2025
North America
- Book
- April 2023
North America
- Book
- March 2023
North America
- Book
- April 2022
North America

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more